Organogenesis Holdings (ORGO) Depreciation & Amortization (CF) (2018 - 2026)

Organogenesis Holdings' Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $4.2 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) rose 21.2% year-over-year to $4.2 million; the TTM figure through Mar 2026 stood at $16.0 million (up 14.35% YoY), while the FY2025 annual figure was $15.3 million, up 12.11% from the prior year.
• Depreciation & Amortization (CF) was $4.2 million for Q1 2026 at Organogenesis Holdings, up from $4.1 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $4.2 million in Q1 2026 to a low of $1.3 million in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $2.9 million across 5 years, with a median of $3.1 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) decreased 24.83% in 2022, then surged 100.0% in 2023.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $1.5 million in 2022, then jumped by 96.96% to $3.0 million in 2023, then rose by 21.23% to $3.6 million in 2024, then gained by 12.48% to $4.1 million in 2025, then gained by 2.66% to $4.2 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $4.2 million (Q1 2026), $4.1 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.